| Serial Number | 90732690 |
| Word Mark | LUCIDA MEDICAL |
| Filing Date | Tuesday, May 25, 2021 |
| Status | 653 - SUSPENSION LETTER - MAILED |
| Status Date | Friday, October 7, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Downloadable software for analysis of medical images and data; Downloadable software for providing medical diagnostic services; Downloadable software in the field of cancer for cancer screening, cancer detection and cancer diagnosis; Downloadable software for screening cancer; Downloadable software for detecting cancer; Downloadable software for diagnosing cancer; Downloadable software for screening, detecting and diagnosing prostate cancer; Downloadable software for the analysis of medical data; Downloadable data analysis software for screening, detecting and diagnosing cancer; Downloadable data analysis software for screening, detecting and diagnosing prostate cancer; Downloadable software for processing medical data; Downloadable data processing software for screening, detecting and diagnosing cancer; Downloadable data processing software for screening, detecting and diagnosing prostate cancer; Downloadable machine learning software for analysis of medical images and data; Downloadable machine learning software for screening, detecting and diagnosing cancer; Downloadable machine learning software for screening, detecting and diagnosing prostate cancer; Downloadable artificial intelligence software for analysis of medical images and data; Downloadable artificial intelligence software for screening, detecting and diagnosing cancer; Downloadable artificial intelligence software for screening, detecting and diagnosing prostate cancer; Downloadable software for MRI machines to detect cancer; Downloadable software for operating medical apparatus in the field of cancer; Downloadable software for medical imaging apparatus to detect cancer; Downloadable publications, namely, magazines, pamphlets, journals, in the field of medicine; Downloadable publications, namely, magazines, pamphlets, journals, in the field of cancer, cancer research, cancer screening, cancer diagnosis, cancer treatment, MRI, MRI machines and medical imaging |
| Translation of Words in Mark | The wording "LUCIDA MEDICAL" has no meaning in a foreign language. |
| Goods and Services | Provision of medical information in the field of prostate cancer; Provision of medical information in the field of cancer, cancer screening, cancer detection and cancer diagnosis; Medical services related to the treatment of cancer; Healthcare services related to the treatment of cancer; Medical analysis services related to the treatment of cancer; Medical analysis services for the diagnosis of cancer; Medical analysis services for the diagnosis of prostate cancer; Medical diagnostic testing, monitoring and reporting services; Medical diagnostic services for cancer; Medical diagnostic services for prostate cancer; Medical consulting services related to the treatment of cancer; Medical consulting services in the field of cancer, cancer screening, cancer detection and cancer diagnosis; Collation being analysis of information in the healthcare sector related to the treatment of cancer; Information and advisory services relating to the aforementioned |
| Disclaimer with Predetermined Text | "MEDICAL" |
| Goods and Services | Software as a service (SaaS) featuring software for analysis of medical images and data; Platform as a service (PaaS) featuring software for analysis of medical images and data; Design and development of software; Software as a service (SaaS) featuring software in the field of cancer for cancer screening, cancer detection and cancer diagnosis; Software as a service (SaaS) featuring software for screening, detecting and diagnosing cancer; Software as a service (SaaS) featuring software for screening, detecting and diagnosing prostate cancer; Software as a service (SaaS) featuring software for the analysis of medical data; Software as a service (SaaS) in the nature of data analysis software for screening, detecting and diagnosing cancer; Software as a service (SaaS) in the nature of data analysis software for screening, detecting and diagnosing prostate cancer; Software as a service (SaaS) featuring software for processing medical data; Software as a service (SaaS) in the nature of data processing software for screening, detecting and diagnosing cancer; Software as a service (SaaS) in the nature of data processing software for screening, detecting and diagnosing prostate cancer; Software as a service (SaaS) in the nature of machine learning software for analysis of medical images and data; Software as a service (SaaS) in the nature of machine learning software for screening, detecting and diagnosing cancer; Software as a service (SaaS) in the nature of machine learning software for screening, detecting and diagnosing prostate cancer; Software as a service (SaaS) in the nature of artificial intelligence software for analysis of medical images and data; Software as a service (SaaS) in the nature of artificial intelligence software for screening, detecting and diagnosing cancer; Software as a service (SaaS) in the nature of artificial intelligence software for screening, detecting and diagnosing prostate cancer; Software as a service (SaaS) featuring software for MRI machines to detect cancer; Software as a service (SaaS) featuring software for medical imaging apparatus to detect cancer; Platform as a service (PaaS) featuring software in the field of cancer for cancer screening, cancer detection and cancer diagnosis; Platform as a service (PaaS) featuring software for screening, detecting and diagnosing cancer; Platform as a service (PaaS) featuring software for screening, detecting and diagnosing prostate cancer; Platform as a service (PaaS) featuring software for the analysis of medical data; Platform as a service (PaaS) in the nature of data analysis software platform for screening, detecting and diagnosing cancer; Platform as a service (PaaS) in the nature of data analysis software platform for screening, detecting and diagnosing prostate cancer; Platform as a service (PaaS) featuring software for the processing of medical data; Platform as a service (PaaS) in the nature of data processing software platform for screening, detecting and diagnosing cancer; Platform as a service (PaaS) in the nature of data processing software platform for screening, detecting and diagnosing prostate cancer; Platform as a service (PaaS) in the nature of machine learning platform for analysis of medical images and data; Platform as a service (PaaS) in the nature of machine learning software platform for screening, detecting and diagnosing cancer; Platform as a service (PaaS) in the nature of machine learning software platform for screening, detecting and diagnosing prostate cancer; Platform as a service (PaaS) in the nature of artificial intelligence software platform for analysis of medical images and data; Platform as a service (PaaS) in the nature of artificial intelligence software platform for screening, detecting and diagnosing cancer; Platform as a service (PaaS) in the nature of artificial intelligence software platform for screening, detecting and diagnosing prostate cancer; Platform as a service (PaaS) featuring software platforms for MRI machines to detect cancer; Platform as a service (PaaS) featuring software platforms for medical imaging apparatus to detect cancer; Design and development of software in the field of cancer, cancer screening, cancer detection and cancer diagnosis; Design and development of software for screening, detecting and diagnosing cancer; Design and development of software for screening, detecting and diagnosing prostate cancer; Design and development of data analysis software; Design and development of data analysis software for screening, detecting and diagnosing cancer; Design and development of data analysis software for screening, detecting and diagnosing prostate cancer; Design and development of data processing software; Design and development of data processing software for screening, detecting and diagnosing cancer; Design and development of data processing software for screening, detecting and diagnosing prostate cancer; Design and development of machine learning software; Design and development of machine learning software for screening, detecting and diagnosing cancer; Design and development of machine learning software for screening, detecting and diagnosing prostate cancer; Design and development of artificial intelligence software; Design and development of artificial intelligence software for screening, detecting and diagnosing cancer; Design and development of artificial intelligence software for screening, detecting and diagnosing prostate cancer; Design and development of software for MRI machines; Design and development of software for medical imaging apparatus; Scientific research services; Scientific research services in the field of cancer, cancer screening, cancer detection and cancer diagnosis; Scientific research services in the field of artificial intelligence and machine learning; Testing of computer software; Information and advisory services relating to the aforementioned |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 19, 2021 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 19, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, August 19, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Lucida Medical Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Cambridge CB42HY GB |
| Event Date | Event Description |
| Friday, April 14, 2023 | SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION |
| Monday, February 13, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, February 13, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, February 13, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, October 7, 2022 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Friday, October 7, 2022 | LETTER OF SUSPENSION E-MAILED |
| Friday, October 7, 2022 | SUSPENSION LETTER WRITTEN |
| Monday, September 12, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, September 12, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, September 10, 2022 | ASSIGNED TO LIE |
| Monday, August 8, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, February 9, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, February 9, 2022 | NON-FINAL ACTION E-MAILED |
| Wednesday, February 9, 2022 | NON-FINAL ACTION WRITTEN |
| Monday, February 7, 2022 | ASSIGNED TO EXAMINER |
| Thursday, August 19, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, May 28, 2021 | NEW APPLICATION ENTERED |